Author:
Torre-Cisneros J.,del Castillo M.,Castón J. J.,Castro M. C.,Pérez V.,Collantes E.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference15 articles.
1. Kroesen S, Widmer AF, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-a therapy. Rheumatology2003;42:617–21.
2. Mikuls TR, Moreland LW. Benefit–risk assessment of infliximab in the treatment of rheumatoid arthritis. Drug Safety2003;26:23–32.
3. Long R, Gardam M. Tumour necrosis factor-α inhibitors and the reactivation of latent tuberculosis infection. Can Med Assoc J2003;168:1153–6.
4. Cunnane G, Doran M, Bresnihan B. Infections and biological therapy in rheumatoid arthritis. Best Pract Res Clin Rheumatol2003;17:345–63.
5. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor a-neutralizing agent. N Engl J Med2001;345:1098–104.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献